Verition Fund Management »

Travere Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $392k 602k 0.65
2022-03-31 $6.6M 6.2M 1.06

More positions owned by Verition Fund Management

Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Amazon (AMZN)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Netflix (NFLX)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
DTE Energy Company (DTE)
Sempra Energy (SRE)
Truist Financial Corp equities Put Option (TFC)
PPL Corporation Call Option (PPL)
Old National Ban (ONB)
Broadcom Put Option (AVGO)
NiSource (NI)

View all positions for Verition Fund Management

Top funds holding Travere Therapeutics

Wolverine Asset Management
D. E. Shaw & Co
Oaktree Capital Management
Graham Capital Management
Silverback Asset Management
Capstone Investment Advisors
Highbridge Capital Management
CNH Partners
Point72 Asset Management
Lazard Asset Management
Readystate Asset Management
Affinity Asset Advisors
Agf Management
Advent Capital Management
BlackRock

View all funds holding Travere Therapeutics